33332-29-5,MFCD03423596
Catalog No.:AA00330Z

33332-29-5 | 2-Amino-5-chloropyrazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$11.00   $8.00
- +
5g
95%
in stock  
$35.00   $25.00
- +
10g
≥98%
in stock  
$43.00   $30.00
- +
100g
98%
in stock  
$393.00 $275.00
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00330Z
Chemical Name:
2-Amino-5-chloropyrazine
CAS Number:
33332-29-5
Molecular Formula:
C4H4ClN3
Molecular Weight:
129.5477
MDL Number:
MFCD03423596
SMILES:
Nc1ncc(nc1)Cl
Properties
Properties
 
BP:
278.4°C at 760 mmHg  
Form:
Solid  
MP:
126 - 128 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
77.7  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.7  

Synonyms
 
  
Upstream Synthesis Route

[1]Patent:US2017/291910,2017,A1,.Locationinpatent:Paragraph0565-0567

[2]Patent:WO2008/85316,2008,A1,.Locationinpatent:Page/Pagecolumn53-54

[3]Patent:WO2005/97778,2005,A1,.Locationinpatent:Page/Pagecolumn15

[4]Patent:WO2004/56369,2004,A1,.Locationinpatent:Page/Pagecolumn24

[5]Patent:WO2005/123723,2005,A1,.Locationinpatent:Page/Pagecolumn11-12

[1]JournalofChemicalResearch,Miniprint,1984,#10,p.2860-2875

[2]JournalofChemicalResearch,Miniprint,1984,#10,p.2860-2875

[1]EuropeanJournalofOrganicChemistry,2016,vol.2016,#36,p.5937-5940

[2]JournalofMedicinalChemistry,2007,vol.50,#19,p.4746-4758

[3]Patent:WO2007/124345,2007,A2,.Locationinpatent:Page/Pagecolumn12;27

[4]JournalofHeterocyclicChemistry,1982,vol.19,#3,p.673-674

[5]Patent:WO2007/124345,2007,A2,.Locationinpatent:Page/Pagecolumn11-12;27

[6]Patent:WO2006/58074,2006,A1,.Locationinpatent:Page/Pagecolumn19-20

[7]Patent:US2017/291910,2017,A1,.Locationinpatent:Paragraph0562-0564

[8]Patent:US2003/225283,2003,A1,.Locationinpatent:Page49-50

[9]AustralianJournalofChemistry,1992,vol.45,#5,p.877-888

[10]Patent:WO2008/85316,2008,A1,.Locationinpatent:Page/Pagecolumn53

[11]Patent:WO2005/97778,2005,A1,.Locationinpatent:Page/Pagecolumn15

[12]Patent:WO2004/56369,2004,A1,.Locationinpatent:Page/Pagecolumn24

[13]Patent:WO2005/123723,2005,A1,.Locationinpatent:Page/Pagecolumn11

[1]Synlett,2002,#7,p.1093-1096

[2]JournalofOrganicChemistry,2008,vol.73,#22,p.8800-8807

[1]Patent:US5866568,1999,A,

Downstream Synthesis Route

[1]EuropeanJournalofOrganicChemistry,2016,vol.2016,p.5937-5940

[2]ChemicalPapers,2019,vol.73,p.1043-1051

[3]OrganicandBiomolecularChemistry,2019,vol.17,p.6342-6345

[4]BioorganicandMedicinalChemistry,2019,vol.27,p.748-759

[5]JournalofMedicinalChemistry,2007,vol.50,p.4746-4758

[6]Patent:WO2007/124345,2007,A2.Locationinpatent:Page/Pagecolumn12;27

[7]JournalofHeterocyclicChemistry,1982,vol.19,p.673-674

[8]Patent:WO2007/124345,2007,A2.Locationinpatent:Page/Pagecolumn11-12;27

[9]Patent:WO2006/58074,2006,A1.Locationinpatent:Page/Pagecolumn19-20

[10]Patent:US2017/291910,2017,A1.Locationinpatent:Paragraph0562-0564

[11]Patent:US2003/225283,2003,A1.Locationinpatent:Page49-50

[12]AustralianJournalofChemistry,1992,vol.45,p.877-888

[13]Patent:WO2008/85316,2008,A1.Locationinpatent:Page/Pagecolumn53

[14]Patent:WO2005/97778,2005,A1.Locationinpatent:Page/Pagecolumn15

[15]Patent:WO2004/56369,2004,A1.Locationinpatent:Page/Pagecolumn24

[16]Patent:WO2005/123723,2005,A1.Locationinpatent:Page/Pagecolumn11

[1]JournalofHeterocyclicChemistry,1983,vol.20,p.947-950

1075-47-4    33332-29-5   
6-Chloro-2-p-tolyl-imidazo1,2-apyrazin-3-ol 

[1]AustralianJournalofChemistry,1992,vol.45,p.877-888

[1]JournalofMedicinalChemistry,1984,vol.27,p.1634-1639

[1]AustralianJournalofChemistry,1992,vol.45,p.877-888

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:33332-29-5 Molecular Formula|33332-29-5 MDL|33332-29-5 SMILES|33332-29-5 2-Amino-5-chloropyrazine
Catalog No.: AA00330Z
33332-29-5,MFCD03423596
33332-29-5 | 2-Amino-5-chloropyrazine
Pack Size: 1g
Purity: 98%
in stock
$11.00 $8.00
Pack Size: 5g
Purity: 95%
in stock
$35.00 $25.00
Pack Size: 10g
Purity: ≥98%
in stock
$43.00 $30.00
Pack Size: 100g
Purity: 98%
in stock
$393.00 $275.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00330Z
Chemical Name: 2-Amino-5-chloropyrazine
CAS Number: 33332-29-5
Molecular Formula: C4H4ClN3
Molecular Weight: 129.5477
MDL Number: MFCD03423596
SMILES: Nc1ncc(nc1)Cl
Properties
BP: 278.4°C at 760 mmHg  
Form: Solid  
MP: 126 - 128 °C  
Storage: Keep in dry area;Room Temperature;  
Complexity: 77.7  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 8  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.7  
63:   
Upstream Synthesis Route
33332-29-5    19745-07-4 

[1]Patent:US2017/291910,2017,A1,.Locationinpatent:Paragraph0565-0567

[2]Patent:WO2008/85316,2008,A1,.Locationinpatent:Page/Pagecolumn53-54

[3]Patent:WO2005/97778,2005,A1,.Locationinpatent:Page/Pagecolumn15

[4]Patent:WO2004/56369,2004,A1,.Locationinpatent:Page/Pagecolumn24

[5]Patent:WO2005/123723,2005,A1,.Locationinpatent:Page/Pagecolumn11-12

6863-77-0    6863-73-6    33332-29-5    33332-28-4 

[1]JournalofChemicalResearch,Miniprint,1984,#10,p.2860-2875

[2]JournalofChemicalResearch,Miniprint,1984,#10,p.2860-2875

5049-61-6    33332-29-5 

[1]EuropeanJournalofOrganicChemistry,2016,vol.2016,#36,p.5937-5940

[2]JournalofMedicinalChemistry,2007,vol.50,#19,p.4746-4758

[3]Patent:WO2007/124345,2007,A2,.Locationinpatent:Page/Pagecolumn12;27

[4]JournalofHeterocyclicChemistry,1982,vol.19,#3,p.673-674

[5]Patent:WO2007/124345,2007,A2,.Locationinpatent:Page/Pagecolumn11-12;27

[6]Patent:WO2006/58074,2006,A1,.Locationinpatent:Page/Pagecolumn19-20

[7]Patent:US2017/291910,2017,A1,.Locationinpatent:Paragraph0562-0564

[8]Patent:US2003/225283,2003,A1,.Locationinpatent:Page49-50

[9]AustralianJournalofChemistry,1992,vol.45,#5,p.877-888

[10]Patent:WO2008/85316,2008,A1,.Locationinpatent:Page/Pagecolumn53

[11]Patent:WO2005/97778,2005,A1,.Locationinpatent:Page/Pagecolumn15

[12]Patent:WO2004/56369,2004,A1,.Locationinpatent:Page/Pagecolumn24

[13]Patent:WO2005/123723,2005,A1,.Locationinpatent:Page/Pagecolumn11

475641-50-0    33332-29-5 

[1]Synlett,2002,#7,p.1093-1096

[2]JournalofOrganicChemistry,2008,vol.73,#22,p.8800-8807

1458-03-3    33332-29-5 

[1]Patent:US5866568,1999,A,

Downstream Synthesis Route
5049-61-6    33332-29-5 

[1]EuropeanJournalofOrganicChemistry,2016,vol.2016,p.5937-5940

[2]ChemicalPapers,2019,vol.73,p.1043-1051

[3]OrganicandBiomolecularChemistry,2019,vol.17,p.6342-6345

[4]BioorganicandMedicinalChemistry,2019,vol.27,p.748-759

[5]JournalofMedicinalChemistry,2007,vol.50,p.4746-4758

[6]Patent:WO2007/124345,2007,A2.Locationinpatent:Page/Pagecolumn12;27

[7]JournalofHeterocyclicChemistry,1982,vol.19,p.673-674

[8]Patent:WO2007/124345,2007,A2.Locationinpatent:Page/Pagecolumn11-12;27

[9]Patent:WO2006/58074,2006,A1.Locationinpatent:Page/Pagecolumn19-20

[10]Patent:US2017/291910,2017,A1.Locationinpatent:Paragraph0562-0564

[11]Patent:US2003/225283,2003,A1.Locationinpatent:Page49-50

[12]AustralianJournalofChemistry,1992,vol.45,p.877-888

[13]Patent:WO2008/85316,2008,A1.Locationinpatent:Page/Pagecolumn53

[14]Patent:WO2005/97778,2005,A1.Locationinpatent:Page/Pagecolumn15

[15]Patent:WO2004/56369,2004,A1.Locationinpatent:Page/Pagecolumn24

[16]Patent:WO2005/123723,2005,A1.Locationinpatent:Page/Pagecolumn11

67-68-5    33332-29-5    87885-44-7 

[1]JournalofHeterocyclicChemistry,1983,vol.20,p.947-950

1075-47-4    33332-29-5   
6-Chloro-2-p-tolyl-imidazo1,2-apyrazin-3-ol 

[1]AustralianJournalofChemistry,1992,vol.45,p.877-888

55153-71-4    33332-29-5    87885-44-7 

[1]JournalofMedicinalChemistry,1984,vol.27,p.1634-1639

33332-29-5    619-41-0    142074-25-7 

[1]AustralianJournalofChemistry,1992,vol.45,p.877-888

Building Blocks More >
576-22-7
576-22-7
2-Bromo-m-xylene
AA00333U | MFCD00000075
870-24-6
870-24-6
2-Chloroethylamine Hydrochloride
AA00336K | MFCD00012887
552-41-0
552-41-0
2'-Hydroxy-4'-methoxyacetophenone
AA00339K | MFCD00008730
625-48-9
625-48-9
2-Nitroethanol
AA0033C5 | MFCD00007405
642-71-7
642-71-7
3,4,5-Trimethoxyphenol
AA0033F8 | MFCD00008389
446273-59-2
446273-59-2
3-Amino-4-bromo-6-chloropyridazine
AA0033I7 | MFCD11520891
33697-81-3
33697-81-3
3-Chloro-4-hydroxyphenylacetic acid
AA0033KZ | MFCD00004349
627-32-7
627-32-7
3-Iodopropanol
AA0033NN | MFCD00060329
185040-32-8
185040-32-8
4-Methylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde
AA0033QS | MFCD04115117
74420-00-1
74420-00-1
1H-Pyrrolo[2,3-b]pyridin-4-amine
AA0033TQ | MFCD07778366
Submit
© 2017 AA BLOCKS, INC. All rights reserved.